Avidity Partners Management as of June 30, 2024
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 85 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intuitive Surgical Com New (ISRG) | 4.6 | $109M | 245k | 444.85 | |
| Boston Scientific Corporation (BSX) | 3.8 | $90M | 1.2M | 77.01 | |
| Natera (NTRA) | 3.5 | $83M | 767k | 108.29 | |
| Arvinas Ord (ARVN) | 3.4 | $80M | 3.0M | 26.62 | |
| Acadia Healthcare (ACHC) | 3.2 | $76M | 1.1M | 67.54 | |
| Dianthus Therapeutics (DNTH) | 3.2 | $76M | 2.9M | 25.88 | |
| Syndax Pharmaceuticals (SNDX) | 2.9 | $69M | 3.3M | 20.53 | |
| Neurocrine Biosciences (NBIX) | 2.9 | $68M | 491k | 137.67 | |
| Avantor (AVTR) | 2.8 | $65M | 3.1M | 21.20 | |
| Cigna Corp (CI) | 2.6 | $61M | 185k | 330.57 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.5 | $58M | 545k | 106.73 | |
| Alnylam Pharmaceuticals (ALNY) | 2.3 | $54M | 222k | 243.00 | |
| Regeneron Pharmaceuticals (REGN) | 2.1 | $50M | 48k | 1051.03 | |
| Illumina (ILMN) | 2.1 | $50M | 478k | 104.38 | |
| Tenet Healthcare Corp Com New (THC) | 2.1 | $50M | 372k | 133.03 | |
| Abbvie (ABBV) | 2.0 | $48M | 278k | 171.52 | |
| Thermo Fisher Scientific (TMO) | 1.9 | $44M | 80k | 553.00 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.8 | $42M | 1.1M | 39.27 | |
| Blueprint Medicines (BPMC) | 1.8 | $41M | 383k | 107.78 | |
| Cg Oncology (CGON) | 1.7 | $41M | 1.3M | 31.57 | |
| Merck & Co (MRK) | 1.7 | $40M | 325k | 123.80 | |
| Ultragenyx Pharmaceutical (RARE) | 1.7 | $40M | 960k | 41.10 | |
| Ideaya Biosciences (IDYA) | 1.7 | $39M | 1.1M | 35.11 | |
| Danaher Corporation (DHR) | 1.6 | $38M | 150k | 249.85 | |
| Janux Therapeutics (JANX) | 1.5 | $35M | 840k | 41.89 | |
| United Therapeutics Corporation (UTHR) | 1.5 | $35M | 110k | 318.55 | |
| Incyte Corporation (INCY) | 1.4 | $32M | 529k | 60.62 | |
| Surgery Partners (SGRY) | 1.3 | $31M | 1.3M | 23.79 | |
| Perspective Therapeutics Com New (CATX) | 1.3 | $30M | 3.0M | 9.97 | |
| Axsome Therapeutics (AXSM) | 1.3 | $30M | 376k | 80.50 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $29M | 754k | 38.99 | |
| Dex (DXCM) | 1.2 | $29M | 259k | 113.38 | |
| Revolution Medicines (RVMD) | 1.2 | $29M | 755k | 38.81 | |
| Insmed Com Par $.01 (INSM) | 1.2 | $29M | 430k | 67.00 | |
| Intra Cellular Therapies (ITCI) | 1.2 | $27M | 400k | 68.49 | |
| Cullinan Oncology (CGEM) | 1.2 | $27M | 1.6M | 17.44 | |
| Glaukos (GKOS) | 1.1 | $27M | 224k | 118.35 | |
| Neurogene (NGNE) | 1.1 | $27M | 728k | 36.39 | |
| Argenx Se Sponsored Adr (ARGX) | 1.1 | $26M | 61k | 430.04 | |
| Mirum Pharmaceuticals (MIRM) | 1.1 | $25M | 731k | 34.19 | |
| Establishment Labs Holdings Ord (ESTA) | 1.0 | $24M | 531k | 45.44 | |
| Immunovant (IMVT) | 1.0 | $24M | 908k | 26.40 | |
| Rocket Pharmaceuticals (RCKT) | 1.0 | $24M | 1.1M | 21.53 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.0 | $23M | 290k | 80.29 | |
| Vaxcyte (PCVX) | 0.9 | $21M | 284k | 75.51 | |
| Apogee Therapeutics (APGE) | 0.8 | $19M | 487k | 39.35 | |
| Jasper Therapeutics Com New (JSPR) | 0.8 | $18M | 782k | 22.70 | |
| Neumora Therapeutics (NMRA) | 0.8 | $18M | 1.8M | 9.83 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.7 | $18M | 398k | 44.29 | |
| Gilead Sciences (GILD) | 0.7 | $18M | 255k | 68.61 | |
| Phathom Pharmaceuticals (PHAT) | 0.7 | $17M | 1.6M | 10.30 | |
| Astrazeneca Sponsored Adr (AZN) | 0.7 | $16M | 205k | 77.99 | |
| Keros Therapeutics (KROS) | 0.7 | $16M | 343k | 45.70 | |
| Biohaven (BHVN) | 0.7 | $16M | 450k | 34.71 | |
| Sanofi Sponsored Adr (SNY) | 0.6 | $15M | 315k | 48.52 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $15M | 1.3M | 11.70 | |
| Context Therapeutics (CNTX) | 0.6 | $15M | 7.4M | 2.00 | |
| EXACT Sciences Corporation (EXAS) | 0.6 | $14M | 339k | 42.25 | |
| Privia Health Group (PRVA) | 0.6 | $13M | 764k | 17.38 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $11M | 559k | 19.21 | |
| Immunome (IMNM) | 0.4 | $11M | 874k | 12.10 | |
| Immunic (IMUX) | 0.4 | $9.9M | 8.9M | 1.11 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.4 | $9.8M | 216k | 45.25 | |
| Cybin Ord | 0.4 | $9.5M | 35M | 0.27 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.4 | $8.6M | 1.7M | 5.16 | |
| Cogent Biosciences (COGT) | 0.4 | $8.4M | 1.0M | 8.43 | |
| Immunocore Hldgs Ads (IMCR) | 0.3 | $6.8M | 200k | 33.89 | |
| Tyra Biosciences (TYRA) | 0.3 | $6.0M | 373k | 15.99 | |
| Uipath Cl A (PATH) | 0.2 | $4.6M | 362k | 12.68 | |
| Spyre Therapeutics Com New (SYRE) | 0.2 | $4.6M | 195k | 23.51 | |
| Immatics SHS (IMTX) | 0.2 | $4.6M | 393k | 11.62 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $4.4M | 93k | 47.66 | |
| Arca Biopharma (ABIO) | 0.2 | $3.8M | 1.0M | 3.83 | |
| Editas Medicine (EDIT) | 0.2 | $3.8M | 816k | 4.67 | |
| Intellia Therapeutics (NTLA) | 0.2 | $3.8M | 170k | 22.38 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.2 | $3.8M | 117k | 32.20 | |
| Prime Medicine (PRME) | 0.2 | $3.6M | 694k | 5.14 | |
| Ac Immune Sa SHS (ACIU) | 0.1 | $3.3M | 825k | 3.99 | |
| Kezar Life Sciences | 0.1 | $3.0M | 5.0M | 0.60 | |
| Scynexis Com New (SCYX) | 0.1 | $2.9M | 1.4M | 2.00 | |
| Karyopharm Therapeutics | 0.1 | $1.8M | 2.0M | 0.87 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $1.7M | 350k | 4.99 | |
| Hyperfine Com Cl A (HYPR) | 0.0 | $1.0M | 1.2M | 0.85 | |
| Caremax Cl A New | 0.0 | $59k | 21k | 2.79 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $1.9k | 12k | 0.16 |
